This viewpoint examines the integration of AI in clinical care and its implications for drug prescription.
Explored the role of AI in clinical settings
Discussed the regulatory framework by the US FDA
Analyzed legal and public health implications
AI has potential to enhance clinical decision-making
Policy and regulatory adaptations are necessary
Legal frameworks need to address AI-related challenges
Abstract
This Viewpoint explores the entry of AI into clinical care, the role of the US Food and Drug Administration, and the associated legal, public health, and medical implications.